Hisamitsu Pharmaceutical Co Inc (4530.T)

4530.T on Tokyo Stock Exchange

22 Jun 2018
Change (% chg)

¥170 (+1.74%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Noven files patent infringement lawsuit against Alvogen
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - ‍Noven Pharmaceuticals :‍Noven Pharmaceuticals says filed lawsuit in a U.S. court against Alvogen and Alvogen pine brook llc for patent infringement.Says Alvogen is seeking approval to market & sell generic version of Minivelle prior to expiration of 2 of Noven's orange book listed patents​.  Full Article

Hisamitsu Pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen - Nikkei
Saturday, 23 Sep 2017 

Sept 22 (Reuters) - Nikkei::Hisamitsu pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen ($111 million) in the March-August period‍​ - Nikkei.Sales of Hisamitsu Pharmaceutical probably fell 1% to about 74 billion yen in the March-August period - Nikkei.Hisamitsu Pharmaceutical Co Inc expected to maintain its guidance for the fiscal year ending February 2018 - Nikkei.  Full Article

Hisamitsu Pharmaceutical unit assigns rights for Brisdelle Capsules and Pexeva Tablets
Tuesday, 26 Jul 2016 

Hisamitsu Pharmaceutical Co Inc <4530.T>:Says its U.S.-based unit, Noven Pharmaceuticals, Inc., has reached agreement to assign rights of approval for manufacture, commercialization and associated intellectual property for Brisdelle(Paroxetine) Capsules, 7.5 mg and Pexeva(Paroxetine Mesylate) Tablets to Sebela International Limited.  Full Article

Hisamitsu Pharmaceutical says private placement of 1 mln treasury stocks
Friday, 8 Jul 2016 

Hisamitsu Pharmaceutical <4530.T>: Says it will distribute 1 million shares of its treasury common stock at 1 yen per share through private placement to The Master Trust Bank of Japan, Ltd. on Aug. 19 .Says it will raise 1 million yen in total through private placement.  Full Article

BRIEF-Hisamitsu Pharmaceutical to set up pharmaceutical import and sales unit in Hong Kong

* Says it will set up a wholly owned pharmaceutical import and sales unit, Hisamitsu Pharmaceutical (Hong Kong) Co., Limited, in February